Pure Global

HbA1c Control - India CDSCO Medical Device Registration

HbA1c Control is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000048_29ad24a3e57465047ef8acf56cd969aa_451c6deb2ae178ebeb81011762871a52. This device is marketed under the brand name NycoCard™ HbA1c. The license holder is Abbott Diagnostics Medical Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
HbA1c Control
UID: IMP/IVD/2020/000048_29ad24a3e57465047ef8acf56cd969aa_451c6deb2ae178ebeb81011762871a52

Brand Name

NycoCard™ HbA1c

Device Class

Class B

Approving Authority

CDSCO

Product Information

The NycoCard™ HbA1c Control contains liquid preparations of stabilized bovine haemoglobin

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing